ViaCyte Inc.
- Raised $54 million (2021)
- 7 clinical trials
- Research grants: $2.7 million
Life science companies
Explore 33,266 biotech, pharmaceutical, medical device, CRO and CDMO companies. Filter by type, location, clinical trials, funding, FDA registrations and research focus, then see the insights or the map. Free, and new companies are added every day.
Gilead Sciences, Inc.
Nasdaq: GILD
- 723 clinical trials, 72 active
- 2 FDA-registered drug sites
- Research grants: $1.2 million
Nuwellis, Inc.
Nasdaq: NUWE
- Raised $3.8 million (2024)
- 9 clinical trials
- FDA-cleared or approved devices
Boston Scientific Corp
NYSE: BSX
- 547 clinical trials, 71 active
- FDA-cleared or approved devices
Catalent
On BioBridgeX
- Raised $650 million (2019)
- 4 clinical trials
Kyntra Bio, Inc.
Nasdaq: KYNB
- Raised $20 million (2014)
- 60 clinical trials, 2 active
- Research grants: $1.2 million
Krystal Biotech, Inc.
Nasdaq: KRYS
- Raised $11 million (2017)
- 18 clinical trials, 11 active
- 1 FDA-registered drug site
- Founded 2017
Annovis Bio, Inc.
NYSE: ANVS
- Raised $1.1 million (2023)
- 8 clinical trials, 3 active
- Research grants: $913,507
- Founded 2008
Aptinyx Inc.
- Raised $70 million (2017)
- 8 clinical trials, 1 active
- Research grants: $5.3 million
- Founded 2015
Beta Bionics, Inc.
Nasdaq: BBNX
- Raised $99 million (2023)
- 2 clinical trials, 1 active
- FDA-cleared or approved devices
- Founded 2015
Huxley Medical, Inc.
- Raised $3 million (2026)
- 3 clinical trials
- FDA-cleared or approved devices
- Research grants: $512,414
NeuroTrack Technologies, Inc.
- Raised $21 million (2019)
- 1 clinical trial
- 1 FDA-registered device site
- Research grants: $6.8 million
Bausch & Lomb Inc
- 231 clinical trials, 11 active
- FDA-cleared or approved devices
- 3 FDA-registered drug sites
Posit Science Corp
- Raised $955,360 (2011)
- 36 clinical trials, 2 active
- 1 FDA-registered device site
- Research grants: $27 million
Akouos, Inc.
- Raised $105 million (2020)
- 5 clinical trials, 5 active
- Research grants: $447,136
- Founded 2016
Avidity Biosciences, Inc.
- Raised $400 million (2024)
- 11 clinical trials, 5 active
- Research grants: $200,000
- Founded 2019
Inhibrx, Inc.
- Raised $200 million (2023)
- Research grants: $2.9 million
- Founded 2017
Lucid Diagnostics Inc.
Nasdaq: LUCD
- Raised $22 million (2024)
- 5 clinical trials, 2 active
- FDA-cleared or approved devices
- Founded 2018
Abiomed Inc
- 33 clinical trials, 12 active
- FDA-cleared or approved devices
- Research grants: $17 million
Immunome Inc.
Nasdaq: IMNM
- Raised $27 million (2021)
- 10 clinical trials, 5 active
- Research grants: $270,025
- Founded 2006
Showing 200 of 33,266 companies
Load morePublished company profiles only; counts update daily. Data licences